STOCK TITAN

Cencora (NYSE: COR) taps Samantha Hammock as new Chief HR Officer

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Cencora, Inc. announced a planned leadership transition in its human resources organization. Executive Vice President and Chief Human Resources Officer Silvana Battaglia will retire from her role effective July 12, 2026, after a seven-year tenure, and continue as an advisor through the end of 2026. The company stated her decision was not due to any disagreement regarding operations, policies, or practices.

Samantha (Sam) Hammock will join Cencora as Executive Vice President and Chief Human Resources Officer effective July 13, 2026, reporting to CEO Bob Mauch and serving on the enterprise leadership team. She previously held senior HR roles at Verizon Communications and American Express. The press release highlights Cencora’s scale, including more than 51,000 team members, over $300 billion in annual revenue, and Fortune 500 and Global 500 rankings, underscoring the strategic importance of the CHRO role.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Retirement effective date July 12, 2026 Silvana Battaglia retirement as EVP and CHRO
Successor start date July 13, 2026 Samantha Hammock begins as EVP and CHRO
Advisor role end End of 2026 Battaglia serves as special advisor through year-end
Annual revenue More than $300 billion Cencora annual revenue level cited in release
Team members More than 51,000 Cencora worldwide workforce size
Fortune 500 ranking #10 Cencora position on Fortune 500 list
Global Fortune 500 ranking #17 Cencora position on Global Fortune 500 list
Chief Human Resources Officer financial
"Silvana Battaglia, Executive Vice President and Chief Human Resources Officer (CHRO), has announced she will retire"
The chief human resources officer is the senior executive who leads a company's people strategy—hiring, pay and benefits, training, workplace culture, legal compliance, and leadership development—like a head coach who builds and keeps the team. Investors care because the CHRO’s choices shape productivity, labor costs, turnover, regulatory risk and succession of key leaders; those outcomes affect a company’s profitability, growth potential and reputation in ways that show up on the balance sheet.
Regulation FD Disclosure regulatory
"Item 7.01 Regulation FD Disclosure. On June 15, 2026, the Company issued a press release"
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
Fortune 500 financial
"Cencora is ranked #10 on the Fortune 500 and #17 on the Global Fortune 500"
The Fortune 500 is a list of the 500 biggest companies in the United States, ranked by their total sales or revenue each year. It’s like a ranking of the top players in the business world, showing which companies are the most successful and influential. Being on the list indicates a company’s importance in the economy.
Global Fortune 500 financial
"ranked #10 on the Fortune 500 and #17 on the Global Fortune 500 with more than $300 billion in annual revenue"
pharmaceutical solutions organization technical
"Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001140859 0001140859 2026-06-10 2026-06-10 0001140859 us-gaap:CommonStockMember 2026-06-10 2026-06-10 0001140859 COR:Sec2.875SeniorNotesDue2028Member 2026-06-10 2026-06-10 0001140859 COR:Sec3.625SeniorNotesDue2032Member 2026-06-10 2026-06-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 10, 2026

 

 

 

Cencora, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Commission File Number: 1-16671

 

Delaware   23-3079390
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

1 West First Avenue Conshohocken, PA   19428-1800
(Address of principal executive offices)   (Zip Code)

 

(610) 727-7000

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of exchange on which registered
Common stock COR New York Stock Exchange (NYSE)
2.875% Senior Notes due 2028 COR28 New York Stock Exchange (NYSE)
3.625% Senior Notes due 2032 COR32 New York Stock Exchange (NYSE)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 15, 2026, Cencora, Inc. (the “Company”) announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer of the Company effective July 12, 2026. Ms. Battaglia will serve in an advisory capacity through the end of 2026. Ms. Battaglia’s decision to retire from her position was not the result of a disagreement on any matter related to the Company’s operations, policies or practices.

 

Ms. Battaglia will be succeeded by Samantha L. Hammock, who will join the Company as Executive Vice President and Chief Human Resources Officer effective July 13, 2026. Ms. Hammock most recently served as Executive Vice President and Chief Human Resources Officer of Verizon Communications Inc.

 

Item 7.01 Regulation FD Disclosure.

 

On June 15, 2026, the Company issued a press release announcing the retirement of Ms. Battaglia and the appointment of Ms. Hammock as Executive Vice President and Chief Human Resources Officer. A copy of the press release is attached as Exhibit 99.1.

 

The information in this Item 7.01 of this Current Report, including Exhibit 99.1 hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

 (d) Exhibits.

 

Exhibit

Number

Description
   
99.1 Press Release of Cencora, Inc., dated June 15, 2026.
104 Cover Page Interactive Data File (formatted as Inline XBRL)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Cencora, Inc.
       
Date:  June 15, 2026 By: /s/ Elizabeth S. Campbell
    Name: Elizabeth S. Campbell
    Title: Executive Vice President and Chief Legal Officer

 

 

 

Exhibit 99.1

 

 

 

Cencora Announces Samantha Hammock as Chief Human Resources Officer

Silvana Battaglia to retire after distinguished 7-year tenure

 

CONSHOHOCKEN, PA, June 15, 2026 — Cencora, Inc. (NYSE: COR) today announced that Silvana Battaglia, Executive Vice President and Chief Human Resources Officer (CHRO), has announced she will retire from the company following a distinguished seven-year tenure. She will be succeeded by Samantha (Sam) Hammock, who will join Cencora as Executive Vice President and CHRO, effective July 13, 2026.

 

“During her seven years of leadership, Silvana has made critical, lasting contributions to Cencora during a time of significant growth,” said Robert P. Mauch, President and Chief Executive Officer of Cencora. “Her global vision strengthened our culture and championed meaningful progress in how we invest in and care for our team members. We wish her all the best in her retirement.”

 

“I am incredibly proud of what our HR team has accomplished over the past seven years — building a world-class employee experience for more than 51,000 team members,” said Ms. Battaglia. “I will leave knowing that our team members have the tools and resources they need to support Cencora’s success in the years ahead.” Ms. Battaglia will transition to a special advisor role for Cencora, effective July 13, 2026, and will work closely with Ms. Hammock through the end of the calendar year to ensure a successful transition.

 

In her role as CHRO, Ms. Hammock will report to CEO Bob Mauch as a member of the Company’s enterprise leadership team and be responsible for setting and implementing Cencora’s global human resources strategy. Mr. Mauch added, “We are excited to welcome Sam to Cencora. Sam’s experience leading human resources strategy at scale with technology-forward thinking and building high-performing teams make her a valuable addition to our team as we continue advancing our growth priorities and our purpose.”

 

“I am honored to join Cencora, a company whose purpose of creating healthier futures is reflected every day through its critical role at the center of the global pharmaceutical supply chain,” said Ms. Hammock. “Great organizations are built by great people. I look forward to working with Bob and the leadership team to advance Cencora’s workforce transformation, strengthen its culture and empower team members to grow, thrive and help shape the company’s future.”

 

Ms. Hammock joins Cencora from Verizon Communications, where she most recently served as Executive Vice President and Chief Human Resources Officer. Prior to Verizon, she held various executive roles across HR at American Express, including serving as their Head of Global Talent and Learning.

 

About Cencora

 

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #17 on the Global Fortune 500 with more than $300 billion in annual revenue. Learn more at investor.cencora.com

 

Contact:

 

Investors:

Melissa O’Brien

Vice President, Investor Relations

Melissa.Obrien@cencora.com

 

Media:

Mike Iorfino

Director, Public Relations

Mike.Iorfino@cencora.com

 

 

 

FAQ

What executive leadership change did Cencora (COR) announce in this 8-K?

Cencora announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer, effective July 12, 2026, and will be succeeded by Samantha (Sam) Hammock as Executive Vice President and CHRO starting July 13, 2026.

When will Silvana Battaglia retire from Cencora (COR) and what is her transition role?

Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer effective July 12, 2026. She will transition to a special advisor role on July 13, 2026 and support Cencora through the end of 2026 to ensure leadership continuity.

Who is Samantha Hammock, the new CHRO of Cencora (COR)?

Samantha (Sam) Hammock will become Executive Vice President and Chief Human Resources Officer of Cencora on July 13, 2026. She previously served as Executive Vice President and Chief Human Resources Officer at Verizon Communications and held senior HR roles at American Express.

How large is Cencora’s workforce and revenue base mentioned in the announcement?

Cencora highlighted that its team has built a world-class employee experience for more than 51,000 team members. The company also noted it generates more than $300 billion in annual revenue, emphasizing the scale at which its human resources organization operates globally.

What rankings and scale did Cencora (COR) emphasize in the CHRO announcement?

Cencora noted it is ranked number 10 on the Fortune 500 and number 17 on the Global Fortune 500, with more than $300 billion in annual revenue. These rankings underscore its position as a large global pharmaceutical solutions organization with significant operational scope.

Filing Exhibits & Attachments

5 documents